Astute Medical, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$3.2M
Doctors Paid
804
Transactions
2,191
2024 Total
$104,587
Payment Breakdown by Category
Research$1.8M (55.0%)
Royalty/License$546,317 (17.1%)
Consulting$320,183 (10.0%)
Food & Beverage$44,223 (1.4%)
Travel$41,027 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.8M | 463 | 55.0% |
| Royalty or License | $546,317 | 21 | 17.1% |
| Consulting Fee | $320,183 | 70 | 10.0% |
| Honoraria | $195,337 | 151 | 6.1% |
| Gift | $183,770 | 127 | 5.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $78,551 | 40 | 2.5% |
| Food and Beverage | $44,223 | 909 | 1.4% |
| Travel and Lodging | $41,027 | 85 | 1.3% |
| Education | $20,793 | 285 | 0.7% |
| Entertainment | $2,474 | 40 | 0.1% |
Payments by Type
Research
$1.8M
463 transactions
General
$1.4M
1,728 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| AST-132 Diamond | $705,215 | 0 | 212 |
| AST-017 Healthy Adult | $345,172 | 0 | 109 |
| Alternate Decisions for Dialysis for AKI (ADD-AKI) | $317,399 | 0 | 7 |
| AST-134 Turquoise | $112,939 | 0 | 30 |
| AST-134 TURQUOISE | $91,587 | 0 | 9 |
| Markers of Acute Pediatric Appendicitis | $53,283 | 0 | 29 |
| AST 132 Diamond | $27,778 | 0 | 19 |
| Function test using neutralized antibody against TIMP2 and IGFBP7 in CLP mice | $24,759 | 0 | 3 |
| Utility of NEPHROCHECK Test System as an early marker of AKI in patients with head and neck cancer undergoing cisplatin-based chemotherapy | $13,559 | 0 | 4 |
| Nephroclear - Diamond | $13,000 | 0 | 1 |
| ADD-AKI | $10,000 | 0 | 1 |
| Study to Identify and Validate Novel Biomarkers from Vascular Surgery Patients at Risk for Acute Kidney Injury | $5,400 | 0 | 3 |
| Study to Identify and Validate Novel Biomarkers from Acutely Ill Patients at Risk for Acute Kidney Injury | $5,400 | 0 | 3 |
| AMI003-08 VAS/AST-105 | $5,400 | 0 | 3 |
| Study to Identify and Validate Novel Biomarkers from Heart Surgery Patients at Risk for Acute Kidney Injury | $3,600 | 0 | 2 |
| Evaluation of Novel Biomarkers from Acutely Ill Patients at Risk for Acute Kidney Injury | $3,600 | 0 | 2 |
| Evaluation of Novel Biomarkers From Acutely Ill Patients at Risk for Acute Kidney Injury | $3,600 | 0 | 2 |
| AMI005-10 AKI/AST-111 | $3,600 | 0 | 2 |
| AMI001-08 AKI/AST-106 | $3,600 | 0 | 2 |
| Identification and Validation of Biomarkers of Acute Kidney Injury Recovery | $3,242 | 0 | 5 |
| A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury | $500.00 | 0 | 1 |
| Kinetics of cell-cycle arrest biomarkers after contrast exposure in patients at high risk for contrast induced nephropathy | $355.43 | 0 | 11 |
| Free hemoglobin in extracorporeal therapy decreases nitric oxide bioavailability and leads to oxidative stress and decreased end organ perfusion | $208.40 | 0 | 1 |
| PICS | $137.60 | 0 | 1 |
| Navigate AKI | $137.20 | 0 | 1 |
Payments by Medical Specialty
Top Paid Doctors — Page 2
| Doctor | Specialty | Location | Total | 2018 |
|---|---|---|---|---|
| Carlos Pancorvo, M.d, M.D | Nephrology | Desoto, TX | $448.95 | $0 |
| Carmine Gianatiempo, Md, MD | Undersea and Hyperbaric Medicine | Englewood, NJ | $400.00 | $0 |
| Joel Santora, Md, MD | Internal Medicine | Ocoee, FL | $345.08 | $0 |
| Hugh Vangelder, Md, MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Tavares, FL | $317.44 | $0 |
| Dr. James Rodier, D.o, D.O | Emergency Medicine | Columbus, GA | $304.87 | $0 |
| Dr. Ajit Sawhney, M.d, M.D | Nephrology | Fountain Valley, CA | $303.81 | $0 |
| Laurae Rettig, Md, MD | Emergency Medicine | Cincinnati, OH | $296.14 | $0 |
| Anand Reddy, Md, MD | Nephrology | Odessa, TX | $292.19 | $0 |
| Dr. Keith Habeeb, D.o, D.O | Surgical Critical Care | Nashville, TN | $280.53 | $0 |
| Dr. Herman Gaztambide-Rodriguez, Md, MD | Critical Care Medicine | Ocoee, FL | $261.40 | $0 |
| Antonio Velardi, Md, MD | Internal Medicine | Ocoee, FL | $261.40 | $0 |
| Kaveh Bagheri, M.d, M.D | Critical Care Medicine | La Mesa, CA | $253.99 | $0 |
| Dr. Sajeet Sawhney, M.d, M.D | Nephrology | Fountain Valley, CA | $246.84 | $0 |
| Fortune Alabi, Md, MD | Pulmonary Disease | Kissimmee, FL | $243.91 | $0 |
| Prof. Paul Digiorgi, Md, MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Port Charlotte, FL | $233.87 | $0 |
| Sherwin Imlay, Md, MD | Anatomic Pathology & Clinical Pathology | Pontiac, MI | $227.93 | $0 |
| Sarat Khandavalli, M.d, M.D | Anatomic Pathology & Clinical Pathology | Wyoming, MI | $227.90 | $0 |
| Kurt Bowman, Md, MD | Critical Care Medicine | Orange City, FL | $226.97 | $0 |
| Taryn Turner, D.o, D.O | Internal Medicine | Granbury, TX | $225.48 | $0 |
| Dr. Parin Makadia, Md, MD | Student in an Organized Health Care Education/Training Program | Desoto, TX | $222.79 | $0 |
| Dr. Kevin Sierra, M.d, M.D | Pulmonary Disease | Tampa, FL | $215.02 | $0 |
| Dr. Adarsh Sharma, M.d, M.D | Pulmonary Disease | Newport Beach, CA | $211.56 | $0 |
| Kianoush Banaei Kashani, M.d, M.D | Nephrology | Rochester, MN | $209.57 | $0 |
| Dr. Howard Reynolds, M.d, M.D | Specialist | Baltimore, MD | $207.42 | $0 |
| Dr. Danielle Davison, M.d, M.D | Critical Care Medicine | Washington, DC | $206.96 | $0 |
Ad
Top Products
- NephroCheck Test Kit $977,896
- Nephrocheck $486,082
Associated Products (8)
- NephroCheck Test Kit $998,041
- Nephrocheck $631,189
- Nephrocheck Test $451,048
- NEPHROCHECK TEST $372,069
- NEPHROCHECK $291,612
- NephroCheck Test $284,818
- NephroCheck Meter $106,095
- NEPHROCHECK Liquid Control Kit $32,780
Payment Categories
- Food & Beverage $44,223
- Consulting $320,183
- Travel & Lodging $41,027
- Research $1.8M
- Royalties $546,317
About Astute Medical, Inc.
Astute Medical, Inc. has made $3.2M in payments to 804 healthcare providers, recorded across 2,191 transactions in the CMS Open Payments database. In 2024, the company paid $104,587. The top product by payment volume is NephroCheck Test Kit ($977,896).
Payments were distributed across 48 medical specialties. The top specialty by payment amount is Critical Care Medicine ($97,299 to 93 doctors).
Payment categories include: Food & Beverage ($44,223), Consulting ($320,183), Research ($1.8M), Travel & Lodging ($41,027), Royalties ($546,317).
Astute Medical, Inc. is associated with 8 products in the CMS Open Payments database, including NephroCheck Test Kit, Nephrocheck, and Nephrocheck Test.